Sohag University
Sohag, 82511, Egypt
NCT Number: NCT07662187
This study aimed to evaluate the endometrial cavity by hysteroscopy after different conservative management of placenta accrete spectrum (PAS), that has impact on the future fertility outcome and menstrual pattern of patients.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Not applicable
Sohag, 82511, Egypt
Placenta Accreta Spectrum is usually associated with maternal morbidity and mortality. The morbidly adherent placenta spectrum includes, placenta accreta when the placenta invades the endometrium beyond Nitabuch's layer of decidua basalis, placenta increta when the placenta invades the myometrium, and placenta percreta when the placenta invades the uterine serosa.
The risk factors of PAS include previous caesarean section (CS), previous myomectomy, placenta previa, and damage of Nitabuch's layer following intrauterine infection and/or endometrial curettage.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients underwent resection and reconstruction.
Patients underwent cervical eversion and pouch closure.
Patients underwent anterior and posterior sutures.
Time frame: 3 months after cesarean section
Assessment of endometrial cavity restoration by office hysteroscopy 3 months after conservative management of placenta accreta spectrum.
Sohag University
Other
Evaluation of Endometrial Cavity After Conservative Management of PAS Patients by Hysteroscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02729974
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
View Trial DetailsNCT02302573
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Poitiers, France
View Trial DetailsNCT06220760
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Asyut, Asyut Governorate, Egypt
View Trial DetailsNCT05471102
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Cairo, Egypt
View Trial Details